At AAIC 2025, the founder and CEO at Veravas discussed the company’s VeraBIND tau pathology blood test, highlighting its potential to detect Alzheimer disease earlier with high accuracy. [WATCH TIME: 4 minutes]
John Forrest
Advertisement
Founder and CEO at Veravas.
Articles by John Forrest
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
How Multiple Sclerosis Affects Men
2
ECTRIMS Congress 2025: Top Expert Interviews and Key Takeaways
3
NeurologyLive® Brain Games: October 12, 2025
4
The Future of Disease-Modifying Therapy in Epilepsy
5
